Ironwood Pharmaceuticals (STU:I76) Days Sales Outstanding : 122.30 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Ironwood Pharmaceuticals Days Sales Outstanding?

Ironwood Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was €92.3 Mil. Ironwood Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was €68.9 Mil. Hence, Ironwood Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 122.30.

The historical rank and industry rank for Ironwood Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

STU:I76' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.37 Med: 94.01 Max: 112.26
Current: 98.93

During the past 13 years, Ironwood Pharmaceuticals's highest Days Sales Outstanding was 112.26. The lowest was 69.37. And the median was 94.01.

STU:I76's Days Sales Outstanding is ranked worse than
74.05% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs STU:I76: 98.93

Ironwood Pharmaceuticals's Days Sales Outstanding increased from Mar. 2023 (101.91) to Mar. 2024 (122.30).

Ironwood Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Ironwood Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ironwood Pharmaceuticals Days Sales Outstanding Chart

Ironwood Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

83.62

117.47

100.43

98.84

102.22

Ironwood Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															101.91	100.32	96.98	99.51	122.30

Competitive Comparison of Ironwood Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Ironwood Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ironwood Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ironwood Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ironwood Pharmaceuticals's Days Sales Outstanding falls into.

Ironwood Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ironwood Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (108.992	+	118.405)	/	2 )	/	405.988	*	365
=	113.6985					/	405.988	*	365
=	102.22

Ironwood Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (118.405	+	66.254)	/	2 )	/	68.887	*	365 / 4
=	92.3295					/	68.887	*	365 / 4
=	122.30

Ironwood Pharmaceuticals (STU:I76) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Ironwood Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ironwood Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Ironwood Pharmaceuticals (STU:I76) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ironwood Pharmaceuticals Inc (STU:I76) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IRWD:USA I76:Germany

Address

100 Summer Street, Suite 2300, Boston, MA, USA, 02110

Website

https://www.ironwoodpharma.com

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ironwood Pharmaceuticals (STU:I76) Headlines

No Headlines